Innoviva (INVA) Cash & Current Investments (2010 - 2026)

Innoviva (INVA) posted Cash & Current Investments of $603.1 million for Q1 2026, up 9.46% on a QoQ basis from $550.9 million in Q4 2025, and up 89.0% year-over-year from $319.1 million in Q1 2025.

Innoviva (INVA) Cash & Current Investments (2010 - 2026) Analysis & Trends

Innoviva's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $603.1 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 89.0% year-over-year to $603.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $603.1 million (up 89.0% YoY) and the FY2025 annual result came in at $550.9 million, up 80.66% from the prior year.
  • Cash & Current Investments was $603.1 million for Q1 2026 at Innoviva, up from $550.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $603.1 million in Q1 2026 and bottomed at $144.0 million in Q1 2023.
  • A 5-year average of $299.5 million and a median of $283.6 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 555.45% — and 2023, when it sank 40.21%.
  • Innoviva's Cash & Current Investments stood at $291.0 million in 2022, then tumbled by 33.51% to $193.5 million in 2023, then surged by 57.59% to $305.0 million in 2024, then surged by 80.66% to $550.9 million in 2025, then climbed by 9.46% to $603.1 million in 2026.
  • Business Quant data shows INVA's Cash & Current Investments at $603.1 million in Q1 2026, $550.9 million in Q4 2025, and $476.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Innoviva 1.58 Bn 979.49 Mn 75.83 Mn 603.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 603.09 Mn
Dec 31, 2025 550.94 Mn
Sep 30, 2025 476.51 Mn
Jun 30, 2025 397.53 Mn
Mar 31, 2025 319.09 Mn
Dec 31, 2024 304.96 Mn
Sep 30, 2024 260.63 Mn
Jun 30, 2024 217.00 Mn
Mar 31, 2024 178.36 Mn
Dec 31, 2023 193.51 Mn
Sep 30, 2023 180.00 Mn
Jun 30, 2023 173.03 Mn
Mar 31, 2023 144.05 Mn
Dec 31, 2022 291.05 Mn
Sep 30, 2022 301.07 Mn
Jun 30, 2022 283.58 Mn
Mar 31, 2022 216.80 Mn
Dec 31, 2021 201.53 Mn
Sep 30, 2021 135.12 Mn
Jun 30, 2021 43.27 Mn